GLP‑1 Implant Benefits

Vivani's pipeline includes a portfolio of GLP‑1 based implants for metabolic diseases, including obesity and type 2 diabetes. These implants are designed to provide patients with the opportunity to realize the full potential benefit of their medication by avoiding daily or weekly administration challenges associated with oral and injectable medications.